Exelixis (EXEL) Divestments (2010 - 2015)
Exelixis' (EXEL) quarterly Divestments came in at $95000.0 in Q1 2015, down 88.12% quarter-over-quarter from $800000.0 in Q3 2014.
Exelixis (EXEL) Divestments (2010 - 2015) Analysis & Trends
Exelixis' Divestments history runs 3 years deep, the most recent figure standing at $95000.0 for Q1 2015.
- On a quarterly basis, Divestments changed N/A year-over-year to $95000.0 in Q1 2015; TTM through Jun 2015 was $895000.0, a N/A change from a year earlier, with the FY2014 full-year figure at $838000.0, changed N/A from the prior year.
- Divestments eased to $95000.0 in Q1 2015 per EXEL's latest filing, from $800000.0 in the prior quarter.
- Across five years, Divestments topped out at $800000.0 in Q3 2014 and bottomed at $95000.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -32.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 95,000.00 |
| Sep 30, 2014 | 800,000.00 |
| Dec 31, 2010 | 400,000.00 |